Posts in tag

Health Care/Life Sciences


The U.S. economy expanded rapidly in the first quarter, growing at a 6.4% annual rate and extending what economists project will be a robust, consumer-led recovery from the pandemic this year. The jump in U.S. gross domestic product in the first three months of the year, reported by the Commerce Department on Thursday, put the …

Healthy, young volunteers who have previously had COVID-19 will be deliberately exposed to coronavirus for a second time to see how the immune system responds, as part of a new U.K. study. Researchers at the University of Oxford on Monday launched the “human challenge” trial to investigate what happens when volunteers who have recovered from the …

Shares of Roper Technologies Inc. ROP, +0.81% inched 0.81% higher to $421.58 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, +0.77% rising 0.77% to 4,128.80 and the Dow Jones Industrial Average DJIA, +0.89% rising 0.89% to 33,800.60. This was the stock’s second …

Credit Suisse Group AG A fire sale of stocks by a large U.S. investor burned Credit Suisse and Nomura Holdings Inc. The global investment banks said Monday that they could incur substantial losses after Bill Hwang’s firm Archegos Capital Management and its banks began liquidating huge positions in blue-chip companies. Large banks served as prime …

U.S. officials said they were told AstraZeneca PLC may have released outdated information in its disclosure of trial results for its Covid-19 vaccine that could have “provided an incomplete view of the efficacy data.” The statement from the National Institute of Allergy and Infectious Diseases came a day after AstraZeneca released interim data from large-scale …

Shares of Align Technology Inc. ALGN, +0.22% inched 0.22% higher to $530.60 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +0.70% rising 0.70% to 3,940.59 and the Dow Jones Industrial Average DJIA, +0.32% rising 0.32% to 32,731.20. This was the stock’s second …

Moderna Inc. MRNA 4.87% has begun studying its Covid-19 vaccine in children aged six months to 11 years in the U.S. and Canada, the latest effort to widen the mass-vaccination campaign beyond adults. The Cambridge, Mass. company said Tuesday that the first children have received doses in the study, which Moderna is conducting in collaboration …

Text size These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from March 4 through March 10, …

Text size A scene inside the Oscar Center in the Brooklyn borough of New York. Kholood Eid/Bloomberg Oscar Health, the insurance-technology company backed by Josh Kushner, is slated to go public early next month, two people familiar with the situation said.  Oscar is scheduled to price its deal on March 2, and trade the next …

Mayo Clinic, like many health providers, has been pushed to its limits by the Covid-19 pandemic. Its intensive-care units were often filled to or near capacity in 2020. And while doctors throughout the health system rushed to find ways to care for the wave of sick patients infected by the new virus, many of the …